BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7060546)

  • 1. Methods and approaches for assessing immunotoxicity: an overview.
    Dean JH; Luster MI; Boorman GA
    Environ Health Perspect; 1982 Feb; 43():27-9. PubMed ID: 7060546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New approaches to immunotoxicity testing.
    Archer DL
    Environ Health Perspect; 1982 Feb; 43():109-13. PubMed ID: 7037382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotoxicity assessment: screening and function studies.
    Vos JG
    Arch Toxicol Suppl; 1980; 4():95-108. PubMed ID: 7002113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procedures available to examine the immunotoxicity of chemicals and drugs.
    Dean JH; Luster MI; Boorman GA; Lauer LD
    Pharmacol Rev; 1982 Mar; 34(1):137-48. PubMed ID: 6280211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approaches and considerations for the assessment of immunotoxicity for environmental chemicals: a workshop summary.
    Boverhof DR; Ladics G; Luebke B; Botham J; Corsini E; Evans E; Germolec D; Holsapple M; Loveless SE; Lu H; van der Laan JW; White KL; Yang Y
    Regul Toxicol Pharmacol; 2014 Feb; 68(1):96-107. PubMed ID: 24280359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing human biologicals in animal host resistance models.
    Burleson GR; Burleson FG
    J Immunotoxicol; 2008 Jan; 5(1):23-31. PubMed ID: 18382855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Issues with introducing new immunotoxicology methods into the safety assessment of pharmaceuticals.
    Dean JH
    Toxicology; 1997 Apr; 119(1):95-101. PubMed ID: 9129200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can host resistance assays be used to evaluate the immunotoxicity of pharmaceuticals?
    Wierda D
    Hum Exp Toxicol; 2000 Apr; 19(4):244-5. PubMed ID: 10918515
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program's guidelines for immunotoxicity evaluation in mice.
    Luster MI; Munson AE; Thomas PT; Holsapple MP; Fenters JD; White KL; Lauer LD; Germolec DR; Rosenthal GJ; Dean JH
    Fundam Appl Toxicol; 1988 Jan; 10(1):2-19. PubMed ID: 3280374
    [No Abstract]   [Full Text] [Related]  

  • 10. Adequate immunotoxicity testing in drug development.
    Herzyk DJ; Gore ER
    Toxicol Lett; 2004 Apr; 149(1-3):115-22. PubMed ID: 15093256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotoxicology: an overview.
    Dean JH; Thurmond LM
    Toxicol Pathol; 1987; 15(3):265-71. PubMed ID: 3317766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of immunobiological effects induced by chemicals, drugs or food additives. I. Tier testing and screening approach.
    Dean JH; Padarathsingh ML; Jerrells TR
    Drug Chem Toxicol; 1979; 2(1-2):5-17. PubMed ID: 548256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotoxicology in the pharmaceutical industry.
    Norbury KC
    Environ Health Perspect; 1982 Feb; 43():53-9. PubMed ID: 7037389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune system as a target organ for toxicity.
    Bick PH
    Environ Health Perspect; 1982 Feb; 43():3-7. PubMed ID: 7037386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk.
    Kavlock R; Dix D
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):197-217. PubMed ID: 20574897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory immunotoxicology: does the published evidence support mandatory nonclinical immune function screening in drug development?
    Snodin DJ
    Regul Toxicol Pharmacol; 2004 Dec; 40(3):336-55. PubMed ID: 15546688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity characterization of environmental chemicals by the US National Toxicology Program: an overview.
    Chhabra RS; Bucher JR; Wolfe M; Portier C
    Int J Hyg Environ Health; 2003 Aug; 206(4-5):437-45. PubMed ID: 12971699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological aspects of toxicology: premises not promises.
    Yoshida S; Golub MS; Gershwin ME
    Regul Toxicol Pharmacol; 1989 Feb; 9(1):56-80. PubMed ID: 2667038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The National Toxicology Program and immunological toxicology.
    Moore JA; Huff JE; Dean JH
    Pharmacol Rev; 1982 Mar; 34(1):13-6. PubMed ID: 7071122
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.